Indicaton
Addressing with a pathogen focused approach Gram-negative hospital acquired infections caused by Acinetobacter baumannii.
Addressing with a pathogen focused approach Gram-negative hospital acquired infections caused by Acinetobacter baumannii.
Fosmanogepix is a novel-class i.v. and oral antifungal with activity against yeasts and molds.